Domingo, E., Camps, C., Kaisaki, P., Parsons, M., Mouradov, D., Pentony, M., . . . Tomlinson, I. (2018). Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent. Elsevier.
Chicago-viite (17. p.)Domingo, E., et al. Mutation Burden and Other Molecular Markers of Prognosis in the QUASAR2 Clinical Trial of Colorectal Cancer Treated with Curative Intent. Elsevier, 2018.
MLA-viite (9. p.)Domingo, E., et al. Mutation Burden and Other Molecular Markers of Prognosis in the QUASAR2 Clinical Trial of Colorectal Cancer Treated with Curative Intent. Elsevier, 2018.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.